Monitoring Neonatal Abstinence Syndrome with a wearable device
Wireless Wearable with AI Analytics for Monitoring Neonatal Abstinence Syndrome (NAS)
This study is testing a new wearable device called Neomonki that helps doctors keep an eye on newborns with Neonatal Abstinence Syndrome by tracking their symptoms in real-time, making it easier to provide better care for these babies.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rekovar INC. NIH-funded |
| Lab location | 1 site (Lake Forest, UNITED STATES) |
| Project ID | NIH-11039621 on NIH RePORTER |
What this research studies
This research focuses on developing a wearable device called Neomonki that continuously monitors newborns experiencing Neonatal Abstinence Syndrome (NAS). The device uses advanced biosensor technology to track behavioral and physiological symptoms, providing real-time data to healthcare professionals. By utilizing artificial intelligence algorithms, the device aims to improve the accuracy of NAS assessments, reducing the reliance on subjective evaluations. This innovative approach seeks to enhance treatment outcomes and potentially lower the costs associated with NICU care for affected infants.
Who could benefit from this research
Good fit: Ideal candidates for this research are newborns aged 0-4 weeks who are diagnosed with Neonatal Abstinence Syndrome due to in utero opioid exposure.
Not a fit: Patients who are not newborns or those who do not have Neonatal Abstinence Syndrome will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate monitoring and treatment of Neonatal Abstinence Syndrome, improving health outcomes for affected newborns.
How similar studies have performed: Other research has shown promise in using wearable technology for monitoring health conditions, indicating that this approach could be effective for NAS as well.
Where this research is happening
Lake Forest, UNITED STATES
- Rekovar INC. — Lake Forest, United States (Active)
Researchers
- Principal investigator: Sharareh, Shiva — Rekovar INC.
- Study coordinator: Sharareh, Shiva
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.